Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study

IntroductionThis study aimed to identify new clinical phenotypes of microscopic polyangiitis (MPA) using a principal components analysis (PCA)-based cluster analysis.MethodsA total of 189 patients with MPA between May 2005 and December 2021 were enrolled from a multicenter cohort in Japan (REVEAL co...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayana Okazaki, Shogo Matsuda, Takuya Kotani, Keisuke Fukui, Takaho Gon, Ryu Watanabe, Atsushi Manabe, Mikihito Shoji, Keiichiro Kadoba, Ryosuke Hiwa, Wataru Yamamoto, Motomu Hashimoto, Tohru Takeuchi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1450153/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594093853638656
author Ayana Okazaki
Shogo Matsuda
Takuya Kotani
Keisuke Fukui
Keisuke Fukui
Takaho Gon
Ryu Watanabe
Atsushi Manabe
Mikihito Shoji
Keiichiro Kadoba
Ryosuke Hiwa
Wataru Yamamoto
Motomu Hashimoto
Tohru Takeuchi
author_facet Ayana Okazaki
Shogo Matsuda
Takuya Kotani
Keisuke Fukui
Keisuke Fukui
Takaho Gon
Ryu Watanabe
Atsushi Manabe
Mikihito Shoji
Keiichiro Kadoba
Ryosuke Hiwa
Wataru Yamamoto
Motomu Hashimoto
Tohru Takeuchi
author_sort Ayana Okazaki
collection DOAJ
description IntroductionThis study aimed to identify new clinical phenotypes of microscopic polyangiitis (MPA) using a principal components analysis (PCA)-based cluster analysis.MethodsA total of 189 patients with MPA between May 2005 and December 2021 were enrolled from a multicenter cohort in Japan (REVEAL cohort). Categorical PCA and cluster analysis were performed based on clinical, laboratory, and radiological findings. Clinical characteristics and outcomes, including all-cause mortality, respiratory-related mortality, end-stage renal disease (ESRD), and relapse were compared between each cluster.ResultsEleven clinical variables were transformed into four components using categorical PCA and synthetic variables were created. Additionally, a cluster analysis was performed using these variables to classify patients with MPA into subgroups. Four distinct clinical subgroups were identified: Cluster 1 included the renal involvements and diffuse alveolar hemorrhage (DAH)-dominant group (N=33). Cluster 2 comprised the elderly onset systemic inflammation group (N=75). Cluster 3 included patients in the younger-onset limited-organ disease group (N=45). Cluster 4 was comprised of an ILD-predominant group without kidney involvement (N=36). 61 patients died during follow-up, with 32 dying of respiratory-related causes. Additionally, 19 patients developed ESRD and 70 relapsed. Cluster 1 showed the worst ESRD-free survival and relapse rates, whereas Cluster 2 showed the worst overall survival and respiratory-related death-free survival rates among the four groups.ConclusionsOur study identified four unique subgroups with different MPA outcomes. Individualized treatments for each subgroup may be required to improve the prognosis of MPA.
format Article
id doaj-art-b5e019f087814a4f9df60138ac9ea9b1
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-b5e019f087814a4f9df60138ac9ea9b12025-01-20T05:23:55ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.14501531450153Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort studyAyana Okazaki0Shogo Matsuda1Takuya Kotani2Keisuke Fukui3Keisuke Fukui4Takaho Gon5Ryu Watanabe6Atsushi Manabe7Mikihito Shoji8Keiichiro Kadoba9Ryosuke Hiwa10Wataru Yamamoto11Motomu Hashimoto12Tohru Takeuchi13Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Takatsuki, JapanDepartment of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Takatsuki, JapanDepartment of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Takatsuki, JapanFaculty of Societal Safety Sciences, Kansai University, Takatsuki, JapanDepartment of Medical Statistics, Research & Development Center, Osaka Medical and Pharmaceutical University, Takatsuki, JapanDepartment of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, JapanDepartment of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, JapanDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, JapanDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, JapanDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, JapanDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, JapanDepartment of Health Information Management, Kurashiki Sweet Hospital, Kurashiki, JapanDepartment of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, JapanDepartment of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Takatsuki, JapanIntroductionThis study aimed to identify new clinical phenotypes of microscopic polyangiitis (MPA) using a principal components analysis (PCA)-based cluster analysis.MethodsA total of 189 patients with MPA between May 2005 and December 2021 were enrolled from a multicenter cohort in Japan (REVEAL cohort). Categorical PCA and cluster analysis were performed based on clinical, laboratory, and radiological findings. Clinical characteristics and outcomes, including all-cause mortality, respiratory-related mortality, end-stage renal disease (ESRD), and relapse were compared between each cluster.ResultsEleven clinical variables were transformed into four components using categorical PCA and synthetic variables were created. Additionally, a cluster analysis was performed using these variables to classify patients with MPA into subgroups. Four distinct clinical subgroups were identified: Cluster 1 included the renal involvements and diffuse alveolar hemorrhage (DAH)-dominant group (N=33). Cluster 2 comprised the elderly onset systemic inflammation group (N=75). Cluster 3 included patients in the younger-onset limited-organ disease group (N=45). Cluster 4 was comprised of an ILD-predominant group without kidney involvement (N=36). 61 patients died during follow-up, with 32 dying of respiratory-related causes. Additionally, 19 patients developed ESRD and 70 relapsed. Cluster 1 showed the worst ESRD-free survival and relapse rates, whereas Cluster 2 showed the worst overall survival and respiratory-related death-free survival rates among the four groups.ConclusionsOur study identified four unique subgroups with different MPA outcomes. Individualized treatments for each subgroup may be required to improve the prognosis of MPA.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1450153/fullthe running head: clinical subtypes in MPA (microscopic polyangiitis)principal component analysiscluster analysisprognosisreal world evidence
spellingShingle Ayana Okazaki
Shogo Matsuda
Takuya Kotani
Keisuke Fukui
Keisuke Fukui
Takaho Gon
Ryu Watanabe
Atsushi Manabe
Mikihito Shoji
Keiichiro Kadoba
Ryosuke Hiwa
Wataru Yamamoto
Motomu Hashimoto
Tohru Takeuchi
Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study
Frontiers in Immunology
the running head: clinical subtypes in MPA (microscopic polyangiitis)
principal component analysis
cluster analysis
prognosis
real world evidence
title Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study
title_full Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study
title_fullStr Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study
title_full_unstemmed Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study
title_short Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study
title_sort identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis multicenter reveal cohort study
topic the running head: clinical subtypes in MPA (microscopic polyangiitis)
principal component analysis
cluster analysis
prognosis
real world evidence
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1450153/full
work_keys_str_mv AT ayanaokazaki identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT shogomatsuda identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT takuyakotani identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT keisukefukui identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT keisukefukui identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT takahogon identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT ryuwatanabe identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT atsushimanabe identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT mikihitoshoji identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT keiichirokadoba identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT ryosukehiwa identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT wataruyamamoto identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT motomuhashimoto identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy
AT tohrutakeuchi identificationofnovelclinicalsubtypesinpatientswithmicroscopicpolyangiitisusingclusteranalysismulticenterrevealcohortstudy